Fighting brain cancer at its root – ScienceBlog.com

McGill University researchers identify proteins that drive cancer stem cells. Targeting and supressing a particular protein called galectin1 could provide a more effective treatment for glioblastoma, in combination with radiation therapy. Due to its resistance to therapy, glioblastoma is the most common and aggressive cancerous brain tumour in adults.

Read more
University of Zurich and Airbus to advance production of human tissue in space – SpaceWatch.Global

Image: Airbus Edinburgh, 27 August 2021. The next ISS supply flight will bring tissue stem cells from two women and two men of different ages to the International Space Station to further advance the industrial production of human tissue in zero-gravity, Airbus said. The experiment will be carried out on the Space Hub of the University of Zurich (UZH) and Airbus Defence and Space

Read more
Incyte Announces Health Canada Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or…

- Minjuvi is an important new therapeutic option for eligible patients with DLBCL in Canada, addressing an urgent unmet medical need - This marks the first marketing authorization by Health Canada for Incyte since establishing Incyte Biosciences Canada in April 2020 MONTREAL, Aug. 24, 2021 /CNW/ - Incyte (Nasdaq: INCY) today announced that Health Canada has granted a Notice of Compliance with conditions for Minjuvi (tafasitamab), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, who are not eligible for autologous stem cell transplant (ASCT). Incyte Biosciences Canada Logo (CNW Group/Incyte Biosciences Canada) "The data from L-MIND demonstrated that eligible patients treated with tafasitamab and lenalidomide had a high likelihood of benefit, which was durable in many cases," said Dr.

Read more
New discovery may lead to more effective treatments for osteoarthritis, other cartilage diseases – News-Medical.net

New information from a study reported on in STEM CELLS might result in more effective treatments for osteoarthritis and other cartilage diseases, as well as hereditary disorders affecting cartilage development. Their findings might also point to a new way to accelerate stem cell differentiation for bioengineering cartilage, the researchers say. The team, from Cytex Therapeutics (Durham, N.C.) and Washington University (St

Read more
Leukemia in adults: Common types, symptoms, and treatment – Medical News Today

Leukemia is a type of cancer that affects white blood cells. Although leukemia can develop in children, there are several types of the condition that doctors most often diagnose in adults. The types of leukemia that can occur in adults include: Leukemia can cause symptoms such as fatigue, weight loss, frequent infections, anemia, and bleeding or bruising easily.

Read more
Catching up with OMRF: New NIH grant, research connects gut health and ability to heal, Griffin named president of int’l research org | GreaterOKC -…

A grant to investigate the link between viral infection and autoimmunity, new published findings from an OMRF scientist connecting gut health with healing ability and the announcement that an OMRF scientist has been named president of the North American Vascular Biology Organization highlight recent news fromthe Innovation District'sOklahoma Medical Research Foundation. The National Institutes of Health has awarded the Oklahoma Medical Research Foundation $480,000 to investigate the long-term effects of viral infections on autoimmunity. OMRF scientist Umesh Deshmukh, Ph.D., received the two-year grant to study how viral infections such as Covid-19 can influence the development of autoimmune diseases

Read more
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services – Business Wire

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies and Hubrecht Organoid Technology (HUB) have announced that they have signed an agreement for the use of tissue-derived organoidsincluding lung, intestinal, and liver organoidsfor use in preclinical toxicology screening and non-cancer drug development services to be offered by the Contract Assay Services division of STEMCELL. These services will help researchers and organizations working on drug development incorporate organoids into their preclinical testing programs and bring new therapeutics to market faster and more cost-effectively

Read more
What the Ancestral Brains of Arthropods Looked Like – Technology Networks

Exquisitely preserved fossils left behind by creatures living more than half a billion years ago reveal in great detail identical structures that researchers have long hypothesized must have contributed to the archetypal brain that has been inherited by all arthropods. Arthropods are the most diverse and species-rich taxonomic group of animals and include insects, crustaceans, spiders and scorpions, as well as other, less familiar lineages such as millipedes and centipedes

Read more